Folks I will have a new product by this Thursday from Dr.
Folks I will have a new product by this Thursday from Dr. Mitchell here is some info on the product, its going to be one of the very best on the market also.
2-PATH SALES SHEET
VitaminCBD™ Dual Pathway in its Fight against Anxiety 2020
Hemp Commodity Industries, LLC (HCI) VitaminCBD™ is Maine’s own organic hemp lifestyle retailer. Nature Inspired-Medically Researched-Patient Tested- VitaminCBD™ is one of Maine’s leading health and wellness hemp retailers. A new formulation for an age-old problem. ANXIETY!
Inspired by our medical and agricultural roots, our labs blend powerful ingredients drawn from nature and science to create affordable lifestyle wellness products. Nature inspired. Third-party tested.
There are two pathways used in this new formulation. Both of these different pathways are used to counter inflammation and anxiety. Both pathways are being activated by way of the Cannabinoid Pathway in two different ways, a major piece of overlooked research until now.
The first pathway operates as an acid form from the main precursor CBG-A. CBD-A has been somewhat overlooked with societies rush to get to CBD. CBD-A is normally found in the raw cannabis plant in low concentrations and is often suggested to chew raw hemp to get this very special benefit. CBD-A is a powerful Cox2 inhibitor with exponential power over serotonin receptors compared to CBD and all its recent rage!
The second pathway is a neutrally charged Cannabinoid known as CBD. CBD works on the Endocannabinoid System (ECS) with CB1 and CB2 receptors. Both of these pathways with our new special formulation gives us a new tincture with a major emphasis that may help to fight anxiety in these trying times of COVID-19.
What truly hope is that Dalton an Mitchell could team up they would in my opinion make an amazing team.
T
12
Univec Conglomerate Inc (UNVC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
Top 5 Most Recently Viewed Articles
US Business Activity Surges to New Heights A significant measure of business activity in the U.S. has surged to its highest level in 31 months, driven by optimism surrounding potential lower interest rates and expected pro-business changes from the incoming administration. Composite PMI Index Shows Strong Growth S&P Global reported that its flash U.S. Composite PMI Output...
Continue Reading
Yiren Digital's Upcoming Presentation at Investor Conference Yiren Digital, a pioneering AI-driven platform that offers a wide array of financial and lifestyle services in China, is preparing for an important virtual event. On September 25, Yuning Feng, the CFO of Yiren Digital, will present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference. This event is an...
Continue Reading
HiLabs Honored by KLAS for Innovations in Healthcare HiLabs, a prominent name in AI-driven healthcare data management, has recently been recognized in the 2025 KLAS Collaborative Points of Light awards. This prestigious acknowledgment showcases HiLabs' commitment to solving significant challenges within the healthcare sector through innovative technology. The company's...
Continue Reading
Booz Allen Hamilton Holding Corp. (NYSE: BAH) just served up some intriguing corporate moves with its Executive Vice President and Chief Financial Officer, Matthew Calderone, making headlines. He recently sold off 3,865 shares of the company's Class A Common Stock for a substantial total of $618,400. That kind of action doesn’t happen in a vacuum; it's a signal that...
Continue Reading
The Dark Side of AI in Cybersecurity In today's digital battleground, the stakes just got higher. IBM has dropped the 2026 X-Force Threat Intelligence Index, and it ain't pretty. We're talking about a seismic 44% spike in cyberattacks leveraging public-facing applications, all thanks to AI that gives attackers a turbo boost to find chinks in the armor. Ransomware Groups...
Continue Reading